MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Revenue
$11,407K
Net Income
-$9,187K
Net Profit Margin
-80.54%
EPS
-$0.16
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Revenue
11,407
13,205
11,566
11,213
Cost of goods sold
1,508
1,762
1,906
1,802
Gross profit
9,899
11,443
9,660
9,411
Research and development
3,137
2,570
5,176
3,923
Sales and marketing
11,416
7,973
6,839
7,163
General and administrative
5,159
4,171
6,659
5,657
Loss from operations
-9,813
-3,271
-9,014
-7,332
Interest income
457
177
170
134
Interest expense
1,490
1,452
1,460
1,423
Change in fair value of sepa, warrant and revenue base redemption liabilities
2,569
11
-2,932
-330
Change in fair value of contingent earnout liability
996
5,147
-2,524
-700
Other income (expense), net
90
-71
-94
-40
Loss before income taxes
-9,183
-9,753
-10,806
-8,291
Income tax benefit (expense)
4
0
5
-3
Net loss
-9,187
-9,753
-10,811
-8,288
Series a preferred stock conversion inducement
-
23,894*
18,516
-
Deemed dividend related to seriesb-2 preferred stock down round provision
-
-23,894*
11,947
-
Undeclared dividends on series a preferred stock
0
-1,426
0
714
Net loss attributable to common stockholders
-9,187
-8,327
-41,274
-9,002
Basic EPS
-0.16
-0.22
-0.96
-0.27
Diluted EPS
-0.16
-0.22
-0.96
-0.27
Basic Average Shares
58,296,711
37,897,785*
43,057,632
32,899,297
Diluted Average Shares
58,296,711
37,897,785*
43,057,632
32,899,297
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
TLSI Income Statement Sankey Diagram
Sankey diagram visualizing TLSI income statement for the period
Net loss
attributable to common...
-$9,187K
(-2.06%↓ Y/Y)
Net loss
-$9,187K
(-10.85%↓ Y/Y)
Loss before income
taxes
-$9,183K
(-10.76%↓ Y/Y)
Income tax benefit
(expense)
$4K
(233.33%↑ Y/Y)
Change in fair value of
sepa, warrant and...
$2,569K
(878.48%↑ Y/Y)
Revenue
$11,407K
(1.73%↑ Y/Y)
Interest income
$457K
(241.04%↑ Y/Y)
Other income
(expense), net
$90K
(325.00%↑ Y/Y)
Loss from operations
-$9,813K
(-33.84%↓ Y/Y)
Gross profit
$9,899K
(5.19%↑ Y/Y)
Interest expense
$1,490K
(4.71%↑ Y/Y)
Change in fair value of
contingent earnout...
$996K
(242.29%↑ Y/Y)
Cost of goods sold
$1,508K
(-16.32%↓ Y/Y)
Sales and marketing
$11,416K
(59.37%↑ Y/Y)
General and
administrative
$5,159K
(-8.80%↓ Y/Y)
Research and development
$3,137K
(-20.04%↓ Y/Y)
Buy us a coffee
TriSalus Life Sciences, Inc. (TLSI)
TriSalus Life Sciences, Inc. (TLSI)